The Promise of Human Embryonic Stem Cells in Aging-Associated Diseases
Author Information
Author(s): Yabut Odessa, Bernstein Harold S.
Primary Institution: Cardiovascular Research Institute, San Francisco, CA
Hypothesis
Human embryonic stem cells (hESCs) can be used to treat aging-associated diseases due to their unique capacity for self-renewal and pluripotency.
Conclusion
hESCs show great potential for developing therapies to regenerate lost cells and restore tissue function in aging-associated diseases.
Supporting Evidence
- Human embryonic stem cells can differentiate into all tissue-specific cell types.
- Numerous hESC lines have been developed and characterized for research.
- Clinical trials are underway to test hESC-derived therapies for aging-associated diseases.
Takeaway
Scientists think that special cells from embryos can help fix problems in older people's bodies, like when their cells stop working properly.
Methodology
The review discusses the derivation, maintenance, and properties of hESCs, as well as methods for directing their differentiation into specific cell types.
Potential Biases
Potential bias may arise from the authors' affiliations and funding sources related to stem cell research.
Limitations
The review does not provide specific experimental data or results, focusing instead on theoretical applications and challenges.
Want to read the original?
Access the complete publication on the publisher's website